Tag: Drug Development

Drug development is the process of bringing a new pharmaceutical drug to the market once a lead compound has been identified through the process of drug discovery. It includes pre-clinical research on microorganisms and animals, filing for regulatory status for an investigational new drug to initiate clinical trials on humans, and may include the step of obtaining regulatory approval with a new drug application to market the drug.

International Conference “Harmonization of approaches to pharmaceutical development”

The RUDN University’s scientific events are authoritative platforms for business communication among scientists, postgraduate and international students, thereby ensuring a possibility of testing scie...

Novotech CRO acquires Clinical Network Services

Novotech, the largest Asia-Pacific-based CRO, has acquired Australasian specialist CRO Clinical Network Services to expand services for early phase product development and clinical research.

Heidelberg Pharma and Magenta Therapeutics prolongate a research cooperation

drug development
Heidelberg Pharma announced that its partner Magenta Therapeutics exercises its option to further continue the development of an Antibody Targeted Amanitin Conjugate.

SK Biopharmaceuticals created novel drug development platform

drug discovery
SK Biopharmaceuticals, the new drug development unit of South Korea’s conglomerate SK Group, had finished developing an artificially intelligent drug development and design platform.

Fujifilm developed new technology to advance the process of drug development

FUJIFILM has developed AI and simulation technology capable of automatically searching and designing new drug candidates from the structural formula of a known biologically active compound.

Aptar Pharma launches a new drug development support kit

lab equipment
Aptar Pharma in combination with Schott Glass and EMA Pharmaceuticals, announced the launch of Aptar Pharma QuickStart™ for injectable drug development.

Otsuka extended collaboration on digital medicines with Proteus Digital Health

Otsuka Pharmaceutical and Proteus Digital Health announce the signing of an expanded global collaboration agreement that will strengthen the relationship between the two companies.

Themis Bioscience signs licensing agreement with Max-Planck-Innovation

Themis announced that it has entered into a license agreement with Max-Planck-Innovation GmbH, the technology transfer agency of the Max Planck Society in Germany.

MEI Pharma and BeiGene will jointly develop cancer drugs

laboratory test
MEI Pharma and BeiGene announced a clinical collaboration to evaluate the safety and efficacy of MEI's ME-401 in combination with BeiGene's zanubrutinib.

BioIVT acquired donor center and laboratory in London

blood tubes
BioIVT, a leading provider of research models and services for drug development, acquired Clinical Trials Laboratory Services (CTLS), a donor center and laboratory based in London (UK).

BioDuro created new drug discovery center for chemistry and biology

drug discovery
BioDuro, a leading global life sciences contract research and development organization announced that it has established a new drug discovery center for chemistry and biology in San Diego (USA).

Piramal Pharma Solutions launches Xcelerate platform

research tube
Piramal Pharma Solutions (PPS), a global leader in Contract Development and Manufacturing Solutions, announced the launch of its Xcelerate Integrated Solutions™ platform.

Paratek Pharmaceuticals seeks EMA approval for its novel antibiotic

Paratek Pharmaceuticals (USA) announced the acceptance of the submission to the European Medicines Agency (EMA) of the Marketing Authorization Application (MAA) for omadacycline.

European Commission released action plan on paediatrics

The European Medicines Agency and the European Commission’s Directorate-General for Health and Food Safety have published a joint action plan to support the development of medicines for children.

Janssen will develop a new treatment for chronic hepatitis B

janssen j&j
Janssen Pharmaceuticals has entered into an agreement with Arrowhead Pharmaceuticals (USA) for an exclusive, worldwide license to develop and commercialize ARO-HBV.

Evotec launches a new drug discovery initiative with Sanofi

drug discovery
Evotec AG announced that it has established an initiative with Sanofi through the launch of a BRIDGE, called LAB031, designed to accelerate drug discovery across multiple therapeutic areas.